5F-PB-22: Difference between revisions

Line 72:

As synthetic cannabinoids are active in the milligram range (with below 5mg being a common dose), it is important to [[Dosage|use proper precautions when dosing]] to avoid a negative experience.

It is strongly recommended that one use [[responsible ~~substance~~ use|harm reduction practices]] when using this drug.

It is strongly recommended that one use [[responsible drug use|harm reduction practices]] when using this drug.

===Tolerance and addiction potential===

As with other synthetic cannibanoids, the chronic use of 5F-PB-22 can be considered [[Addiction potential::moderately addictive with a high potential for abuse]] and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and [[withdrawal effects]] may occur if a person suddenly stops their usage.

Line 79:

==Legal issues==

5F-PB-22 was developed to bypass ~~substance~~ prohibition laws which have banned the possession and sale of many synthetic cannabinoids. As such, it remains legal in most of the world.

5F-PB-22 was developed to bypass drug prohibition laws which have banned the possession and sale of many synthetic cannabinoids. As such, it remains legal in most of the world.

*'''United Kingdom''' - It is illegal to produce, supply, or import this ~~substance~~ under the Psychoactive Substance Act, which came into effect on May 26th, 2016.<ref>Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted</ref>

*'''United Kingdom''' - It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.<ref>Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted</ref>

*'''United States''' - In January 2014, 5F-PB-22 was designated as a Schedule I controlled substance in the United States.<ref>http://www.deadiversion.usdoj.gov/fed_regs/rules/2014/fr0110_10.htm</ref>

*'''Germany''' - On December 13, 2014 5F-PB-22 was added to the controlled substance act ("BtMG"), making it illegal to produce, sell or possess.<ref>Achtundzwanzigste Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften (28. BtMÄndV)| http://www.buzer.de/gesetz/11392/a189949.htm</ref>

@@ Line 72: / Line 72: @@
 As synthetic cannabinoids are active in the milligram range (with below 5mg being a common dose), it is important to [[Dosage|use proper precautions when dosing]] to avoid a negative experience.
-It is strongly recommended that one use [[responsible substance use|harm reduction practices]] when using this drug.
+It is strongly recommended that one use [[responsible drug use|harm reduction practices]] when using this drug.
 ===Tolerance and addiction potential===
 As with other synthetic cannibanoids, the chronic use of 5F-PB-22 can be considered [[Addiction potential::moderately addictive with a high potential for abuse]] and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and [[withdrawal effects]] may occur if a person suddenly stops their usage.
@@ Line 79: / Line 79: @@
 ==Legal issues==
-F-PB-22 was developed to bypass substance prohibition laws which have banned the possession and sale of many synthetic cannabinoids. As such, it remains legal in most of the world.
+F-PB-22 was developed to bypass drug prohibition laws which have banned the possession and sale of many synthetic cannabinoids. As such, it remains legal in most of the world.
-*'''United Kingdom''' - It is illegal to produce, supply, or import this substance under the Psychoactive Substance Act, which came into effect on May 26th, 2016.<ref>Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted</ref>
+*'''United Kingdom''' - It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.<ref>Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted</ref>
 *'''United States''' - In January 2014, 5F-PB-22 was designated as a Schedule I controlled substance in the United States.<ref>http://www.deadiversion.usdoj.gov/fed_regs/rules/2014/fr0110_10.htm</ref>
 *'''Germany''' - On December 13, 2014 5F-PB-22 was added to the controlled substance act ("BtMG"), making it illegal to produce, sell or possess.<ref>Achtundzwanzigste Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften (28. BtMÄndV)| http://www.buzer.de/gesetz/11392/a189949.htm</ref>